34 results
6-K
EX-99.2
GLPG
Galapagos NV
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
to each Galapagos Program;
(C) review, discuss and, if applicable, provide comments on any materials or information delivered to the JSC pursuant … to the special meeting with an agenda for the meeting and materials reasonably adequate to enable an informed decision on the matters to be considered
6-K
EX-99.7
GLPG
Galapagos NV
24 Mar 22
Galapagos publishes 2021 annual report and announces Biographies of proposed new board members
8:13pm
Exhibit 99.7
Time Sensitive
Materials
Depositary’s Notice of
Extraordinary Shareholders’ Meeting and Annual
Shareholders’ Meeting of Galapagos … are to receive these materials and who are eligible to give voting instructions to the Depositary upon the terms described herein.
Share Record Date:
April 12
6-K
EX-99.3
GLPG
Galapagos NV
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
Materials or Regulatory Approval.
1.21 “Co-Commercialization” means Commercialization activities in or for the Shared Territory, including sales … and marketing activities, Pricing Matters, the local adaptation of global or regional Promotional Materials, strategic marketing, and Medical Affairs
6-K
EX-99.3
GLPG
Galapagos NV
11 May 21
Current report (foreign)
2:10pm
to time.
“Clinical Supply Agreement” means that certain Clinical Materials Supply Agreement, effective February 6, 2017, between the Parties, as may … Materials or Regulatory Approvals, the possession (whether by ownership or license) by a Party or its Affiliates of the ability to assign, grant
6-K
EX-99.10
GLPG
Galapagos NV
29 Mar 24
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
5:03pm
Exhibit 99.10
Time Sensitive
Materials
Depositary’s Notice of Shareholders’ Meetings’ of Galapagos NV
ADSs:
American Depositary Shares (“ADSs … Date:
March 25, 2024 (close of business in New York). Date used to determine ADS Holders who are to receive these materials and who are eligible
6-K
EX-99.5
k2wdgcq
1 Apr 19
Current report (foreign)
12:00am
6-K
EX-99.4
0ybm xw9s
25 Mar 21
Publication of the annual report and invitation to the The annual report for the financial year 2020, including a review of figures and performance, is available online at
12:00am
6-K
EX-99.4
ol6l38e44djlxli
20 Sep 19
Current report (foreign)
4:07pm
6-K
EX-99.5
sc9x1l6mggi235e
27 Mar 20
Publication of the annual report and invitation to the The annual report for the financial year 2019, including a review of figures and performance, is available online at
4:49pm
DRS/A
EX-10
lbvy4so2l 7kgjgv0e9
4 Mar 15
Draft registration statement (amended)
12:00am
424B3
oeupf
15 Oct 18
Prospectus supplement
12:00am
DRS/A
EX-10
2twlrczicv a2aq
4 Mar 15
Draft registration statement (amended)
12:00am
6-K
EX-99.5
5cpws6w44vvrfp70yqt
29 Mar 24
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
5:03pm
6-K
EX-99.1
mo7mes7 8lfo8g
3 Oct 22
Galapagos receives positive CHMP opinion for Jyseleca® European label update based on testicular function safety data from MANTA/RAy studies
6:02pm
20-F
com7bakjysq
25 Mar 16
Annual report (foreign)
12:00am
DRS
4mlew36pz08u
6 Feb 15
Draft registration statement
12:00am